Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings
The episode discusses the implementation of DLL3-Directed BiTE Therapy in community settings for Neuroendocrine Carcinoma.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027. Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. Disclosure information is available at the beginning of the video presentation.
Sponsors
Boehringer Ingelheim Pharmaceuticals, Inc.
More episodes of PeerView Internal Medicine CME/CNE/CPE Audio Podcast